One supplement per row. The dot on the spine is now.
Names and doses only. Every annotation is hidden, not removed — this is the same markup as Full view, so the two cannot disagree. Iron is ALTERNATE DAYS. TAU is Triacetyluridine, not taurine.
Kunitz and Bowman-Birk inhibit trypsin and chymotrypsin only — not lipase, and Creon is dosed in lipase units and titrated on fat absorption. The only surviving concern is CCK / protease-feedback at raw-flour scale. Yardstick — 🔴 NOW HISTORICAL, NOT LIVE ⟨C·8-15⟩: NaturDAO ~96 mg/day legume protein was cleared (32.1 mg × 3 tablets). That product left the regimen 8/15 and its porcine replacement carries ZERO legume protein. The number survives as the highest legume exposure this regimen has cleared in practice, but it is no longer a live intake and must not be cited as one — measure candidates against it as history, not as label presence. ⟨? | a — unsourced in every rev; not on the Creon FDA label⟩
ginseng-polyphenol-class.ala-iron-chelation.saffron-membership.cordyceps 1,000 was right — notable, since three other entries on that chart were stale. ⚠️ Three written restart conditions were not met: not last, not alone (four changes share 8/24), and not half-dose — half is 1 cap/day. Open item 70.xr2-slot-history gains a fourth entry. Adderall 70 mg/day Δ = 0 — this is a clock change, not a dose change.dao-gastric-lead-time. ✅ Taurine does NOT follow it — see dao-slotmate-decoupling.dao-gastric-lead-time established when the −15 min "ceiling" argument was struck.🔴 SUPERSEDED IN FACT 9-01 — the historical claim below stands as written and the geometry moved. XR-2 returned to 11:15 AM fasted ⟨N 9-01⟩, so the fed-state arithmetic in this block describes a placement no longer running. Kept because it is the derivation the 9/1 two-pulse decomposition corrects. Its "~7:40 PM peak" is a midpoint between two bead pulses, not a peak.
🔴 ABSORPTION CHECK RUN AND SHOWN — THE CONSEQUENCE IS LARGER THAN THE 40 MINUTES ON THE CLOCK ⟨C·8-26⟩. Five minutes ahead of the biggest meal of the day, taken with the first fatty bites, is functionally a fed dose.
Adderall XR's own label, at the 30 mg dose: "Food does not affect the extent of absorption … but prolongs Tmax by 2.5 hours (from 5.2 hrs fasted to 7.7 hrs after a high-fat meal)" for d-amphetamine ⟨FDA label, NDA 21-303 — read directly⟩.
📐 Former 11:15 fasted → d-amph peak ~4:25 PM. New 11:55 fed → peak ~7:40 PM. A ~3 h 15 m shift, not 40 minutes. XR-1 → XR-2 peak gap goes 4 h 45 m → 7 h 55 m.
✅ Calibrating the other way, and it matters: the 5/28 → 8/15 placement at 11:45 was also 15 min pre-meal and therefore also fed. He ran a fed XR-2 for roughly two and a half months. The 8/15 move to 11:15 was the anomaly. This is a restoration of a known state, not an experiment.
⚠ Watch: a peak near 7:40 PM sits against gabapentin at 8:45 PM, melatonin at 9:30 PM and sleep onset. If sleep latency changes, this is the first suspect — see open item 76. ✅ AUC and Cmax unchanged — a Tmax shift, not a dose change. 📞 Tell the prescriber: information, not an approval gate.
quercetin-dose-and-unit.dao-substrate-competition — shared polyamine transporter with agmatine, which brackets this slot at 10 AM and 1:45 PM.ir2-slot-history.alcar-split-rationale ⟨?⟩.coffee-ir-acidity-premise.dao-slotmate-decoupling.gabapentin-timing-rederivation.dao-slotmate-decoupling. 📌 The 8/15 “6:25 merged into 6:15” note is now historical: a 6:25 slot exists again but holds only the capsule.dinner-hypotensive-load, −8.3 mmHg diastolic, measured). Kept because the glycemic indication is meal-linked and the eating window is the evening — a real trade, not an oversight.grapeseed-cut is unaffected. Grounds are the unworthy limb of burden-of-proof: SIRT1 mechanism falsified, null in T2D meta-analyses, and the one phenotype-matched mechanism misses on exposure by 40–600×. See resveratrol-cut.dao-per-meal-logic has named since rev 7.45. 🔴 ⚠ Do not judge this one on felt effect — the 8:00 PM slot carries NAC 1,800 mg, 47% of the day’s NAC, and acetylcysteine is a documented DAO inhibitor at >20%. See dao-nac-thiol-collision and open item 83.postprandial-fall, which is falsified (paired delta +3.4 mmHg). ⚠ Glucose-active, so it holds to post-draw alongside agmatine. Confirm 400 mg against the bottle — that figure is carried from this file, not read off a label.taurine-glyr-threshold.mg-bisglycinate-glycine.| Agmatine | 1,000 mg | 🔵 RESTORED ⟨N 8-6⟩, starts 8/7 post-draw. 4 × 250 mg sulfate ≈ 570 mg free base (57.0%) · 12.7 mg/kg. Reinstated on stated benefit — not on the burden rule, whose premise fails here. Dissent preserved in the registry. |
| Vitamin B6 | 16 mg | 25 mg P5P, Infini-B only. >EFSA UL (12), <US UL (100). Standalone P5P rejected 7/22. |
| NAC | 🆕 3,800 mg | 🆕 4 × ND 500 fed (noon · 12:30 PM · 3 PM · dinner) + NOW 600 × 3 at the 8 PM dessert · 48.4 mg/kg · 69% anchor · 106% Lizzo high arm. ✅ Ramp complete ⟨N 8-11⟩. ⚠ +500 above the 3,300 target decided 8/3 — that increment has no indication on file. |
| Selenium | 🆕 75 µg | 8 PM bolus only, at 3 caps. Zero from any other source. 19% of the 400 µg UL. |
| Molybdenum | 🆕 150 µg | 8 PM bolus only, at 3 caps. 7.5% of the 2,000 µg UL. |
| Glycine | 8,235 mg | 🆕 CORRECTED ⟨8-12⟩ — a measurement fix, not a dose change. Labeled 1.5 + 1 + 1.5 + 3 g = 7,000 · plus 1,235 mg obligate from Mg bisglycinate (200 mg elemental ⟨N✓8-12⟩). 104.9 mg/kg. Moves glycine from 89% → 105% of Baylor weight-scaled — a line every prior rev stated the wrong side of. Intake never moved. ⛔ Not a reason to raise NAC — see glynac-1to1-ratio. Indication ⟨N 8-12⟩: daytime doses distributed to pair with NAC timing. |
| Taurine | 4,500 mg | 🆕 THE 500 mgMOVED 4:00 PM → 1:45 PM WITH THE ADDERALL IR ⟨N 8-30⟩ — still six slots, Δ = 0. powder 750 + 750 + 500 + 750 + 750 + 1,000 · cap 1,000 + 1,000 + 500 + 500 + 500 + 1,000 — same total either form. 57.3 mg/kg. Meal-anchored 50.0% powder / 44.4% cap — unchanged, no meal-anchored dose moved. 🔴 Landing from 2:45 PM on RECOMPUTED: 66.7 → 55.6% powder, 55.6 → 44.4% cap (the 500 now lands before 2:45, not after). ✅ Dose CV unchanged at 19.2 / 33.3% — checked, not assumed: the multiset is identical and CV has no time term. 🆕 Intervals re-derived: 4h45 · 2h00 · 1h00 · 3h30 · 2h30 · 10h15 = 24h00 ✓ — the rev 7.35 figures were computed on 3,500 across five slots and are superseded. ⚠️ Now +1,000 over established across TWO named increments — open items 42, 71. 🆕 First safety anchor: Shao & Hathcock OSL 3,000 mg → 150%; highest RCT dose 150 mg/kg/d ≈ 11,775 mg → 38%; Galloway 7-day arm 56.8 mg/kg → 101%. No NOAEL exists — an OSL is where evidence is strong, not where harm begins. ⚠️ Taurine is vasoactive and this hub has never named it as one, against a 57 mmHg diastolic floor. It has run ≥3,500 through the whole 28-day record with no signal — monitored by the 8:00 PM reading, not a reason to hold. 51.0 mg/kg. ⚠️ +500 over the established 3,500 — this one IS an increase, so the scope limit engages. Indication named: sleep support ⟨N 8-12⟩. Reverses the 8/10 cut — yours reversing yours. Full indication ⟨N 8-10⟩: pancreas · glucose management · smoothing anxiety and Adderall. |
| TAU | 80 mg | 40 × 2 · ≠ Taurine |
| ALCAR | 2,500 mg | 1,000 + 500 + 500 + 500 · 6 AM / 10 AM / 1:45 PM / 5 PM |
| L-Theanine | 1,500 mg | 🆕 10 doses ⟨N 9-01⟩ — was 9. The 8/30 consolidation is reversed: 400 mg at 1:45 PM → 200 at 1:45 + 200 at 4:00. 200+100+100+200+100+200+200+100+100+200 = 1,500 ✓. Largest single dose back to 200 mg; open item 84 closes. The TOTAL has never changed — only the spacing did. |
| Myo-Inositol | 2,500 mg | 1,000 + 500 + 500 + 500 |
| L-Glutamine | 15 g | 3 × 5 g · the live mucosal-integrity agent — also the real DAO lever |
| Magtein | 2,001 mg | 667 × 3 · cap or powder, same dose either form. Lands on the ~1.5–2 g/day trial range. |
| Mg elemental | ~345–405 | Magtein ~144 + Mg bisglycinate 200 · single figure now that both forms match. 🆕 ✅ CONFIRMED unchanged ⟨N✓8-12⟩ — this range already assumed the 200 mg was elemental, and it is. Had it been compound weight the bisglycinate would contribute 28 mg and this range would fall to ~173–233. |
| HMB (CaHMB) · Amino-9 Essentials | 0 | 🚫 CUT ⟨N 8-14⟩ — temporary recovery-window adds; window formally closed by Wancata 8/12 ("well healed incision", "OK for activity and diet as tolerated", 1-year follow-up). HMB was a bundle: it carried ~1,000 IU D3 + ~360 mg Ca, and both leave with it. Amino-9 never had a totals line. ⚠ With both EAA sources gone, the weighed-protein item is no longer optional. |
| Curcumin | 1,200 mg | Nanocur 1 g + Longvida 200 |
| OptiMSM | 3,000 mg | 1,500 × 2 |
| NR | 300 mg | 6 AM fasted |
| Synapsa Bacopa | 360 mg | single AM cap |
| Lion’s Mane | 1,000 mg | 500 × 2 · Real Mushrooms, fruiting body |
| 🆕 Turkey Tail | 1,000 mg | 🆕 500 × 2 ⟨N 8-11⟩ — Meal 1 + Dinner. ND powder or Real Mushrooms cap, same dose either form. Closes the “no dose on file” gap. Carries no Se or Mo. |
| Mastic Gum | 1,000 mg | 500 × 2 · 1 capsule per slot ⟨N 8-11⟩. ✅ Total unchanged by the product swap — both products are 500 mg/cap. ⏳ Greco Gum ordered 8/11; CGN until it lands. 🔴 CGN carries oat fiber + ~38 mg elemental Ca/day (in no other total); Greco is filler-free, so both go to zero on arrival. |
| Vitamin E | 200 IU | NOW · low-dose cap, weak vit-K antagonism |
| PEA | 800 mg | 400 × 2 |
| Urolithin A | 1,000 mg | 500 × 2 |
| Boswellia | 700 mg | 350 × 2 |
| Citicoline (Cognizin) | 500 mg | 250 × 2 |
| Vitamin D3 | 7,000 IU | 🆕 Reduced from ~8,000 ⟨N 8-14⟩ — 5,000 (Meal 1) + 2,000 (Meal 2). The ~1,000 IU HMB bundle left with the cut. ⚠ The 8/7 panel’s 25-OH-D + serum Ca were drawn with the bundle on board — an on-HMB reading. |
| Cordyceps | 1,000 mg | 🆕 NEW LINE — LIVE 8/24 ⟨N✓8-24 bottle read⟩. Real Mushrooms CORDYCEPS-M, C. militaris extract, 500 mg × 2 caps, one per slot (6:30 AM + 10:00 AM). 12.7 mg/kg · 8% β-glucans. ⚠️ The one-cap-per-slot split is inferred from the recorded placement, not stated — ⟨?⟩ on the split only. Glucose-active with the Kuhlman draw pending, and antiplatelet-adjacent: open items 69, 70. |
| Supplemental calcium | 0 | 🆕 NOW ZERO ⟨N✓8-24 · label read⟩ — the mastic swap executed. HMB carried ~360 mg/day and left 8/14; CGN mastic carried ~38 mg/day via its dicalcium-phosphate filler and the NutriCology replacement carries no calcium filler (HPMC, MCC, Mg stearate, silicon dioxide). The conclusion holds on a read excipient list — the prior derivation rested on an unverified "filler-free" brand attribution and was right by luck. The 8/10 serum Ca was drawn with that ~38 mg on board and remains a with-calcium reading. ❌ rev 7.40’s “the only calcium source in the regimen” was false — see hmb-bundle. |
| Sodium | ~1,560 mg | ⚠ Do not raise until the mechanism is known. In SIADH this is the wrong direction. |
| 🆕 🩸 Iron (elemental) | 🆕 72 mg alt-day | 🆕 NEW ROW — this table never carried iron ⟨9-03⟩. 4 × 18 mg elemental from NOW Ferrochel; ~36 mg/day averaged. Read the unit: 18 mg elemental from 90 mg of the chelate — never record 90 or 360. Base 36 protected; +36 increment carries its own indication and reversal. |
| ⚕️ 🆕 Pantoprazole | 40 mg | 🆕 NEW ROW — absent from every prior rev ⟨N✓9-03⟩. Once daily, 11:15 AM (moved from 6:00 AM). Prescriber Wancata. ⏳ Continuation undecided pending her answer — open item 91. |
| Adderall | 70 mg | XR 60 + IR 10 · full prescribed |
| Telmisartan | 40 mg | Holds. Reassess ~8/1. |
| Saffron | 30 mg | ND, Crocus sativus stigma, 7.5% crocins / 1.0% safranals · 6:15 AM |
| Panax GS15-4 | 200 mg | ND, 1 cap · 🆕 8:00 AM ⟨N✓9-03⟩ (was 6:00 AM — iron-driven, open item 93) |
| R-ALA (Na-R-ALA) | 300 mg | 🆕 8:00 AM fasted ⟨N✓9-03⟩ (was 6:00 AM — iron-driven, open item 93) |
| Bilberry | 100 mg | LE MirtoSelect, fruit, 36% = 36 mg anthocyanins · 10:00 AM |
| Gymnema | 400 mg | 🔵 restored to 7:45 PM pre-dessert, starts 8/7. ⚠ Confirm the 400 mg against the bottle. |
| MegaSporeBiotic | 1 cap | dinner · started 8/5 |
| L-Citrulline · Chromium · 🆕 Grape Seed | 0 | 🚫 CUT. Citrulline ⟨N 8-6⟩ — real BP case. Chromium ⟨N 8-6⟩ — mechanism mismatch. 🆕 Grape Seed ⟨N 8-11⟩ — Nate's decision, and an independent BP case supports it: 2016 meta (16 trials, n=810) systolic −6.08 / diastolic −2.80, against a 2 mmHg margin. Never carried a dose, so no total changes. |
| Berberine · Potassium | 0 | Berberine held. ✅ 🆕 POTASSIUM VERIFIED CLEAR 8/14 ⟨N✓4⟩ — the VM chart’s KCl 801 mg/day is a stale entry; none is taken and the ARB constraint has never been breached. Chart entry still needs removing — open item 48. |
1. Substrate competition ⟨C·7-22 | i:in-vitro/porcine⟩ — 🔵 The agmatine arm returns 8/7. At 1 g/day it is the largest DAO-substrate load in the stack, crude molar load ≈ 50× dietary histamine. Caveat unchanged: in-vitro porcine — order-of-magnitude flag, not a measurement.
Transporter question closed 7/29 ⟨C·7-29 | DOC:Satriano-2001 · Gründemann-2003 · Winter-2011 · Ramos-Molina-2015⟩ — the Amino-9 collision is falsified. 🆕 (Amino-9 itself was CUT 8/14 ⟨N⟩ — this paragraph is historical.) Agmatine moves on the polyamine transporter (Km 2.5–44 µM) and OCT2/OCT3/MATE1, not the y⁺ cationic amino-acid system; arginine, lysine and ornithine were tested directly and do not compete. The real collision is Spermidine 3 mg at Meal 1 — shared polyamine route. 🔴 LIVE AGAIN from 8/7. This is exactly why no agmatine dose lands at noon: 6:15 AM, 10 AM, 1:45 PM and 5 PM are all clear of the Meal 1 spermidine.
2. Mucosal integrity ⟨C·7-22 | i:villus + GI-disease⟩ — DAO is made by mature villous enterocytes. Post-Frey + Forrest III ulcers + EPI is the likeliest suppressor. Intervention already live: L-Glutamine 15 g/day.
3. Copper ⟨C·7-22 | m:pending⟩ — the actual metal cofactor. Zn:Cu 15:1 is at the 8–15:1 edge. Added to the 8/1 draw. ⚠ Ceruloplasmin is acute-phase — read against CRP.
⚠ HISTORICAL ⟨8-15⟩ — NaturDAO left the regimen 8/15, replaced by Seeking Health DAO Enzyme. Retained because the reasoning still applies to any legume-DAO product: do not switch to NaturDAO Plus — it bundles P5P on the retired rationale. Legumactive is Pisum sativum + Lens culinaris (not grass pea → no β-ODAP concern), supplies catalase alongside DAO, and ~96 mg legume protein/day is ~3 orders below any Creon/trypsin-inhibitor concern.
In T3c with retained C-peptide (1.4, June 2026) and ⟨assumed⟩ impaired glucagon counterregulation, a higher glucose floor with lower variance beats a lower mean with excursions you cannot feel or counter.
🔵 Gymnema is back in from 8/7 — glucose-active, so it drifts numbers down, the opposite direction to this principle. Berberine stays out. Citrulline is cut ⟨N 8-6⟩. If your numbers drift up slightly, that is still not a regression to correct.
⚠ This stands on glucagon-impairment, which is UNMEASURABLE (Garbacz 7/15). Keep it if you want it — but it is an assumption, not physiology.